tolvaptan has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawagishi, N; Kitagataya, T; Kubo, A; Morikawa, K; Nakai, M; Nakamura, A; Ogawa, K; Ohara, M; Sakamoto, N; Shigesawa, T; Sho, T; Suda, G; Suzuki, K; Tokuchi, Y; Umemura, M; Yamada, R | 1 |
| Amin, A; Chiodo, JA; Sanyal, A; Sigal, SH | 1 |
| Ambrosy, A; Blair, JE; Burnett, JC; Campia, U; Cook, T; Gheorghiade, M; Grinfeld, L; Konstam, MA; Maggioni, AP; Metra, M; Pang, PS; Schrier, RW; Swedberg, K; Traver, B; Udelson, JE; Zannad, F | 1 |
| Afdhal, NH; Cárdenas, A; Czerwiec, F; Ginès, P; Guevara, M; Marotta, P; Oyuang, J | 1 |
2 trial(s) available for tolvaptan and Recrudescence
| Article | Year |
|---|---|
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
Topics: Aged; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Cardio-Renal Syndrome; Double-Blind Method; Glomerular Filtration Rate; Hospitalization; Humans; Kaplan-Meier Estimate; Middle Aged; Prospective Studies; Recurrence; Stroke Volume; Tolvaptan; Ventricular Dysfunction, Left | 2011 |
Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis.
Topics: Administration, Oral; Antidiuretic Hormone Receptor Antagonists; Ascites; Benzazepines; Chronic Disease; Female; Health Surveys; Humans; Hyponatremia; Liver Cirrhosis; Male; Middle Aged; Prospective Studies; Recurrence; Sodium; Tolvaptan; Treatment Outcome | 2012 |
2 other study(ies) available for tolvaptan and Recrudescence
| Article | Year |
|---|---|
Durable response without recurrence to Tolvaptan improves long-term survival.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidiuretic Hormone Receptor Antagonists; Female; Follow-Up Studies; Humans; Liver Cirrhosis; Male; Middle Aged; Prognosis; Recurrence; Retrospective Studies; Time Factors; Tolvaptan; Treatment Outcome; Young Adult | 2020 |
Management Strategies and Outcomes for Hyponatremia in Cirrhosis in the Hyponatremia Registry.
Topics: Aged; Antidiuretic Agents; Female; Fluid Therapy; Hospitalization; Humans; Hyponatremia; Isotonic Solutions; Liver Cirrhosis; Male; Middle Aged; Recurrence; Registries; Sodium; Tolvaptan; Treatment Outcome | 2018 |